NRG is a world market leader in the production of medical isotopes. In the Netherlands, NRG is the leading authority with regard to integral radiation protection. NRG operates the High Flux Reactor owned by the European Union. The company has around 500 innovative employees with high quality know-how, and works for and with partners in healthcare, the energy market, industry, government and science.
NRG is an internationally-operating nuclear service provider. The company produces isotopes, conducts nuclear technological research, is a consultant on the safety and reliability of nuclear installations and provides services related to radiation protection. Research is performed for governments aimed at developing knowledge about nuclear technology.